GlassScriptPhysician profile
Danielle Lee Allen-Herried
NPI 1285121061
$1,758.10
in general payments reported to CMS, 2019-2025
13 companies · $71.12 in 2025
The $71.12 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $58.04 · 2022: $352 · 2023: $863 · 2024: $300 · 2025: $71.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663 · Travel and Lodging: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $663.35 |
| Travel and Lodging | $570.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $629.92 | 2023 | Gelpoint V-Path |
| Medical Device Business Services, INC. | $325.00 | 2022 | |
| Hologic Sales and Service, LLC | $212.97 | 2023 | Acessa Provu System, Fluent Fluid Management System |
| Coopersurgical, INC. | $162.51 | 2024 | Paragard T 380a |
| Astellas Pharma US INC | $130.20 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $126.16 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $41.64 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.53 | 2021 | |
| Abbvie INC. | $27.28 | 2022 | |
| Baxter Healthcare | $23.42 | 2025 | Perclot |
| Biogen, INC. | $17.04 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $16.48 | 2025 | |
| Roche Diagnostics Corporation | $15.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Allen-Herried listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.